Internal Medicine Doctors in Manahaukin, NJ Accepting Medicare
1 Internal Medicine doctors found. Showing 1 - 1
 Jatin Karsandas Desani, MD Internal Medicine - Hematology & Oncology Medicare: Accepting Medicare Assignments Practice Location: 1100 Rt 72 West, Ste 340, Manahaukin, NJ 08050 Phone: 609-597-0547 Fax: 609-597-8668 |
News Archive
Camp Okizu's brain tumor weekend program has new benefactor
Camp Okizu, a non-profit camp in northern California for kids with cancer and their families, has a new benefactor for its weekend program for families of children with brain tumors. In honor of Silicon Valley executive James W. Hebert, who died from a brain tumor at age 54 in 2006, his wife, Ronni Sarmanian, also a former tech executive, has committed to sponsor the event. This annual event, which will be called the James W. Hebert Family Camp, begins April 16 and coincides with Hebert's birthday, April 13.
Neuroscience evidence in courts: A double-edged sword
A lawyer is trying to convince a jury that his client really is crazy. It's usually a tough argument to sell in a court of law. But what if the lawyer has a picture of his client's brain that shows there's something biologically wrong with it? Can that evidence help persuade a jury? Should it even be allowed as evidence?
KHN's ‘What the Health?': Trump merges health and immigration
President Donald Trump has merged two of his favorite hot-button topics by requiring new immigrants to either purchase health insurance within 30 days of arrival or prove they can pay for medical expenses on their own.
New data reveals overall decline in e-cigarette use, alarming uptick in use of disposable products by youth
Today, the U.S. Food and Drug Administration, in partnership with the Centers for Disease Control and Prevention, released new data from the 2020 National Youth Tobacco Survey, which show 1.8 million fewer U.S. youth are currently using e-cigarettes compared to 2019.
ImmunoCellular to present new data from ICT-107 Phase I trial on GBM
ImmunoCellular Therapeutics, Ltd., announced today it will present new data from the previously completed Phase I clinical trial of ICT-107, the Company's lead cancer vaccine candidate for the treatment of glioblastoma multiforme (GBM), at the 2012 Annual Meeting of the American Society of Clinical Oncology (ASCO) in Chicago, IL.
› Verified 9 days ago